High glucose induces apoptosis in AC16 human cardiomyocytes via macrophage migration inhibitory factor and c-Jun N-terminal kinase (Q43007648)

12 November 2017

High glucose induces apoptosis in AC16 human cardiomyocytes via macrophage migration inhibitory factor and c-Jun N-terminal kinase (English)

1 reference

12 November 2017

1 reference

Jia-Liang Liang

1

1 reference

12 November 2017

Ding-Zhang Xiao

2

1 reference

12 November 2017

Xiao-Ying Liu

3

1 reference

12 November 2017

Qiu-Xiong Lin

4

1 reference

12 November 2017

Zhi-Xin Shan

5

1 reference

12 November 2017

Jie-Ning Zhu

6

1 reference

12 November 2017

Shu-Guang Lin

7

1 reference

12 November 2017

Xi-Yong Yu

8

1 reference

12 November 2017

1 October 2010

1 reference

Clinical and Experimental Pharmacology and Physiology

12 November 2017

1 reference

12 November 2017

37

1 reference

12 November 2017

10

1 reference

12 November 2017

969-973

1 reference

Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies

12 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

Type 1 diabetes, hyperglycaemia, and the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

Rac1 is required for cardiomyocyte apoptosis during hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

Diabetic cardiomyopathy revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

The role of macrophage migration inhibitory factor on glucose metabolism and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

Macrophage migration inhibitory factor (MIF) tautomerase inhibitors as potential novel anti-inflammatory agents: current developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

Dominant negative 14-3-3 promotes cardiomyocyte apoptosis in early stage of type I diabetes mellitus through activation of JNK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

Cardiomyopathy in offspring of diabetic rats is associated with activation of the MAPK and apoptotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

Mechanisms of high glucose-induced apoptosis and its relationship to diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH(2)-terminal kinase and caspase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

Macrophage migration inhibitory factor induces cardiomyocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

Novel cell lines derived from adult human ventricular cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

Glucose induces apoptosis of cardiomyocytes via microRNA-1 and IGF-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

Distinct effects of high-glucose conditions on endothelial cells of macrovascular and microvascular origins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

Calpain activation contributes to hyperglycaemia-induced apoptosis in cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

Macrophage migration inhibitory factor as a redox-sensitive cytokine in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

Oxidative stress and left ventricular remodelling after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case–Cohort Study, 1984–2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05420.X

10.1111/J.1440-1681.2010.05420.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference